...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Lumboperitoneal shunts for the treatment of normal pressure hydrocephalus
【24h】

Lumboperitoneal shunts for the treatment of normal pressure hydrocephalus

机译:腰腹分流术治疗常压性脑积水

获取原文
获取原文并翻译 | 示例
           

摘要

Ventriculoperitoneal shunt placement is the standard of care for idiopathic normal pressure hydrocephalus (iNPH). Studies have reported shunt complication rates up to 38%, with subdural hemorrhage rates as high as 10%. Lumboperitoneal (LP) shunts with horizontal-vertical valves (HVV) are an alternative for cerebrospinal fluid (CSF) diversion that avoids direct cerebral injury and may reduce the risk of overdrainage. Here we reviewed our experience with LP-HVV shunt placement for iNPH. We retrospectively reviewed our 33 patients with LP-HVV shunts inserted for the treatment of iNPH from 1998 to 2009. Patients were evaluated for improvements in gait, urinary function, and dementia after shunt placement. All patients had evidence of ventriculomegaly and a positive response to pre-operative lumbar puncture or extended lumbar drainage. All 33 (100%) patients had pre-operative gait dysfunction, 28 (85%) had incontinence, and 20 (61%) had memory deficits. Mean follow-up time was 19 months. Following shunt placement, 33/33 (100%) patients demonstrated improved gait, 13/28 (46%) had improvement in incontinence, and 11/20 (55%) had improvement in memory. Shunt failures requiring revision occurred in nine patients (27%), with an average time to failure of 11 months. Infections occurred in two patients (6%). There were no neurologic complications, including no hemorrhages. Thus, LP-HVV shunt placement is a safe and effective alternative to ventriculoperitoneal shunting for iNPH, resulting in significant symptomatic improvement with a low risk of overdrainage. It should be considered as an option for the treatment of patients with iNPH who demonstrate clinical improvement following lumbar drainage.
机译:室腹膜分流放置是特发性正常压力脑积水(iNPH)的治疗标准。研究报告分流并发症发生率高达38%,硬膜下出血发生率高达10%。带水平垂直瓣膜(HVV)的腰腹(LP)分流器是脑脊液(CSF)转移的替代方法,可避免直接脑损伤,并可以减少过度引流的风险。在这里,我们回顾了iNPH的LP-HVV分流器放置的经验。我们回顾性研究了1998年至2009年间共33例经LP-HVV分流术治疗iNPH的患者。对患者进行分流后步态,泌尿功能和痴呆的改善情况进行了评估。所有患者均有心室肥大的证据,术前穿刺或延长腰椎引流反应阳性。所有33例(100%)的患者术前步态障碍,28例(85%)的尿失禁,20例(61%)的记忆障碍。平均随访时间为19个月。分流放置后,33/33(100%)的患者步态得到改善,13/28(46%)的尿失禁得到改善,11/20(55%)的患者记忆得到改善。 9名患者(27%)发生需要翻修的分流失败,平均失败时间为11个月。两名患者(6%)发生感染。没有神经系统并发症,包括出血。因此,对于iNPH,LP-HVV分流放置是脑室腹腔分流的一种安全有效的替代方法,可显着改善症状,并减少过度引流的风险。对于腰椎引流后临床改善的iNPH患者,应考虑将其作为治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号